|
gptkbp:instanceOf
|
gptkb:investor
|
|
gptkbp:country
|
gptkb:United_States
|
|
gptkbp:focusesOn
|
Early-stage biotechnology companies
|
|
gptkbp:foundedIn
|
1980
|
|
gptkbp:headquartersLocation
|
gptkb:Cambridge,_Massachusetts,_United_States
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Atlas Venture
|
|
gptkbp:industry
|
Venture capital
|
|
gptkbp:investedIn
|
gptkb:biotechnology
gptkb:insurance
Life sciences
|
|
gptkbp:managingPartner
|
gptkb:Bruce_Booth
gptkb:Jason_Rhodes
gptkb:Jean-François_Formela
gptkb:Kevin_Bitterman
Peter Barrett
|
|
gptkbp:notableAlumni
|
gptkb:David_Grainger
gptkb:Jean-Charles_Soria
gptkb:Jean-Christophe_Tellier
gptkb:Jean-François_Dufour
gptkb:Jean-Michel_Paul
gptkb:Jean-Paul_Prieels
gptkb:Jean-Philippe_Combal
gptkb:Jean-Pierre_Bizzari
gptkb:Jean-Pierre_Garnier
gptkb:Jean-Pierre_Sommadossi
gptkb:Jean-Yves_Bonnefoy
gptkb:Jean-Yves_Leber
gptkb:Jean-Yves_Tinevez
gptkb:Jean_de_Gunzburg
gptkb:Luc_Dochez
|
|
gptkbp:notableExit
|
gptkb:Alnylam_Pharmaceuticals_IPO
gptkb:Blueprint_Medicines_IPO
gptkb:Editas_Medicine_IPO
gptkb:Intellia_Therapeutics_IPO
gptkb:Spero_Therapeutics_IPO
gptkb:Unum_Therapeutics_IPO
Surface Oncology IPO
|
|
gptkbp:notableInvestment
|
gptkb:Intellia_Therapeutics
gptkb:Alnylam_Pharmaceuticals
gptkb:Editas_Medicine
gptkb:Replimune
gptkb:Surface_Oncology
gptkb:Blueprint_Medicines
gptkb:Spero_Therapeutics
gptkb:Unum_Therapeutics
|
|
gptkbp:previouslyHadEuropeanOffice
|
Yes
|
|
gptkbp:shiftedFocusTo
|
Life sciences
|
|
gptkbp:website
|
https://www.atlasventure.com/
|
|
gptkbp:bfsParent
|
gptkb:AngelList
|
|
gptkbp:bfsLayer
|
5
|